This project is being done to determine whether hypofractionated radiation therapy or the safe reduction of radiation treatment fractions to 10, 8, or 5, may be delivered safely in resected Head and Neck Squamous Cell Carcinoma (HNSCC) patients with intermediate pathologic risk features.
Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers (HART-HN)
Drexel Town Center
Froedtert Menomonee Falls Hospital
Froedtert West Bend Hospital
OPEN TO ACCRUAL